Inhibitor Development against p7 Channel in Hepatitis C Virus

Hepatitis C Virus (HCV) is the key cause of chronic and severe liver diseases. The recent direct-acting antiviral agents have shown the clinical success on HCV-related diseases, but the rapid HCV mutations of the virus highlight the sustaining necessity to develop new drugs. p7, the viroporin protei...

Full description

Bibliographic Details
Main Authors: Shukun Wei, Xiaoyou Hu, Lingyu Du, Linlin Zhao, Hongjuan Xue, Chaolun Liu, James J. Chou, Jin Zhong, Yimin Tong, Shuqing Wang, Bo OuYang
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/5/1350